A critical discovery in cancer research is emerging with the use of nanobodies to re-engage mutated p53. This vital cancer inhibitor protein is frequently disabled in several forms of tumors, resulting uncontrolled https://totalbookmarking.com/story22004570/mini-antibodies-restore-tumor-suppressor-p53-a-promising-pathway-for-cancer-management